Precision BioSciences Inc (DTIL)
6.50
-0.68
(-9.47%)
USD |
NASDAQ |
Nov 21, 16:00
6.73
+0.23
(+3.54%)
Pre-Market: 08:03
Precision BioSciences Enterprise Value: -29.06M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -29.06M |
| November 20, 2024 | -23.85M |
| November 19, 2024 | -24.00M |
| November 18, 2024 | -23.23M |
| November 15, 2024 | -20.47M |
| November 14, 2024 | -19.86M |
| November 13, 2024 | -16.94M |
| November 12, 2024 | -14.72M |
| November 11, 2024 | -14.64M |
| November 08, 2024 | -14.64M |
| November 07, 2024 | -14.33M |
| November 06, 2024 | -14.49M |
| November 05, 2024 | -14.03M |
| November 04, 2024 | -15.33M |
| November 01, 2024 | -9.731M |
| October 31, 2024 | -13.26M |
| October 30, 2024 | -18.56M |
| October 29, 2024 | -17.88M |
| October 28, 2024 | -16.99M |
| October 25, 2024 | -16.31M |
| October 24, 2024 | -15.49M |
| October 23, 2024 | -14.97M |
| October 22, 2024 | -13.25M |
| October 21, 2024 | -12.95M |
| October 18, 2024 | -12.05M |
| Date | Value |
|---|---|
| October 17, 2024 | -11.90M |
| October 16, 2024 | -11.52M |
| October 15, 2024 | -13.17M |
| October 14, 2024 | -12.27M |
| October 11, 2024 | -12.20M |
| October 10, 2024 | -11.90M |
| October 09, 2024 | -11.45M |
| October 08, 2024 | -10.48M |
| October 07, 2024 | -9.804M |
| October 04, 2024 | -8.607M |
| October 03, 2024 | -7.635M |
| October 02, 2024 | -10.48M |
| October 01, 2024 | -10.85M |
| September 30, 2024 | -11.90M |
| September 27, 2024 | -35.61M |
| September 26, 2024 | -35.18M |
| September 25, 2024 | -35.03M |
| September 24, 2024 | -34.60M |
| September 23, 2024 | -33.22M |
| September 20, 2024 | -31.56M |
| September 19, 2024 | -32.57M |
| September 18, 2024 | -31.63M |
| September 17, 2024 | -27.15M |
| September 16, 2024 | -26.35M |
| September 13, 2024 | -26.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-89.17M
Minimum
Mar 24 2023
798.29M
Maximum
Feb 08 2021
144.55M
Average
20.83M
Median
Aug 10 2022
Enterprise Value Benchmarks
| Pfizer Inc | 199.35B |
| Assembly Biosciences Inc | -1.389M |
| Protagonist Therapeutics Inc | 2.014B |
| Alector Inc | -88.98M |
| Entrada Therapeutics Inc | 226.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.42M |
| Revenue (Quarterly) | 0.576M |
| Total Expenses (Quarterly) | 21.85M |
| EPS Diluted (Quarterly) | -2.25 |
| Profit Margin (Quarterly) | -2.85K% |
| Earnings Yield | 0.92% |
| Normalized Earnings Yield | -40.09 |